Angiotensin II-mediated GFR decline in subtotal nephrectomy is due to acid retention associated with reduced GFR

Nephrology Dialysis Transplantation

Volumn 30, Issue 5, 2015, Pages 762-770

  Wesson, Donald E ^a,b   Jo, Chan Hee ^a   Simoni, Jan ^c  

^a SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^c TEXAS TECH UNIVERSITY   (United States)

Author keywords

aldosterone; angiotensin II; bicarbonate; chronic kidney disease; endothelin, microdialysis

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; BICARBONATE; VALSARTAN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; PROTON; TETRAZOLE DERIVATIVE; VALINE;

ACID BASE BALANCE; ACID RETENTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DRUG DOSE COMPARISON; FEMALE; GLOMERULUS FILTRATION RATE; KIDNEY FUNCTION; MALE; MICRODIALYSIS; NEPHRECTOMY; NONHUMAN; PH MEASUREMENT; PRIORITY JOURNAL; RAT; RENAL PROTECTION; URINARY EXCRETION; ANALOGS AND DERIVATIVES; ANIMAL; ANIMAL FOOD; DISEASE MODEL; KIDNEY; METABOLISM; PROCEDURES; WISTAR RAT;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMAL FEED; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GLOMERULAR FILTRATION RATE; KIDNEY; MALE; MICRODIALYSIS; NEPHRECTOMY; PROTONS; RATS; RATS, WISTAR; SODIUM BICARBONATE; TETRAZOLES; VALINE;

EID: 84929575391     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu388     Document Type: Article

References (35)

1. Nath KA, Hostetter MK, Hostetter TH. Pathophysiology of chronic tubulo-interstitial disease in rats-interactions of dietary acid load, ammonia, and complement component C3. J Clin Invest 1985; 76: 667-675
2. Phisitkul S, Hacker C, Simoni J et al. Dietary protein causes a decline in the glomerular filtration rate of the remnant kidney mediated by metabolic acidosis and endothelin receptors. Kid Int 2008; 73: 192-199
3. Anderson S, Meyer TW, Renke HG et al. Control of glomerular hypertension limits progressive glomerular injury in rats with reduced renal mass. J Clin Invest 1985; 76: 612-619
4. Lewis EJ, Hunsicker LC, Bain RP et al. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Eng J Med 1993; 329: 1456-1462
5. Wright JT, Bakris G, Greene T et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease. JAMA 2002; 288: 2421-2431
6. Levine DZ, Iaocovitti M, Buckman S et al. Ang II-dependent HCO3 reabsorption in surviving rat distal tubules: expression/activation of H+-ATPase. Am J Physiol 1997; 272: F799-F808
7. Levine DZ, Iaocovitti M, Luck B et al. Surviving rat distal tubule bicarbonate reabsorption: effects of chronic AT1 blockade. Am J Physiol 2000; 278: F476-F483
8. Wesson DE, Jo C-H, Simoni J. Angiotensin II receptors mediate increased distal nephron acidification caused by acid retention. Kid Int 2012; 82: 1184-1194
9. Mahajan A, Simoni J, Sheather S et al. Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy. Kid Int 2010; 78: 303-309
10. Wesson DE. Dietary HCO3 reduces distal tubule acidification by increasing cellular HCO3 secretion. Am J Physiol 1990; 258: F429-F432
11. Wesson DE, Simoni J. Increased tissue acid mediates progressive GFR decline in animals with reduced nephron mass. Kid Int 2009; 75: 929-935
12. Wesson DE, Simoni J. Acid retention during kidney failure induces endothelin and aldosterone production which lead to progressive GFR decline, a situation ameliorated by alkali diet. Kid Int 2010; 78: 1128-1135
13. Siragy HM, El-Kersh MA, de Gasparo M et al. Differences in AT2-receptor stimulation between AT1-receptor blockers valsartan and losartan quantified by renal interstitial fluid cGMP. J Hypertens 2002; 20: 1157-1163
14. Piecha G, Koleganova N, Gross ML et al. Regression of glomerulosclerosis in subtotally nephrectomized rats: effects of monotherapy with losartan, spironolactone, and their combination. Am J Renal Physiol 2008; 295: F137-F144
15. Blaufox MD, Aurell M, Bubeck B et al. Report of the nephrourology committee on renal clearance. J Nucl Med 1996; 37: 1883-1890
16. Wesson DE. Dietary bicarbonate reduces rat distal nephron acidification evaluated in situ. Am J Physiol 1990; 258: F870-F876
17. Abdel-Rahman EM, Abadir PM, Siragy HM. Regulation of renal 12(S)-hydroxyeicosatetraenoic acid in diabetes by angiontensin AT1 and AT2 receptors. Am J Physiol Regul Integr Comp Physiol 2008; 295: R1473-R1478
18. Sasser J, Pollock JS, Pollock D. Renal endothelin in chronic angiotensin II hypertension. Am J Physiol Regulatory Integrative Physiol 2002; 283: R243-R248
19. Xue C, Siragy HM. Local renal aldosterone system and its regulation by salt, diabetes, and angiotensin type 1 receptor. Hypertension 2005; 46: 584-590
20. Wesson DE, Simoni J, Green DF. Reduced extracellular pH increases endothelin-1 secretion by human renal microvascular cells. J Clin Invest 1998; 101: 578-583
21. Radke KJ, Taylor RE, Jr, Schneider EG. Effect of hydrogen ion concentration on aldosterone secretion by isolated perfused canine adrenal glands. J Endocrinol 1986; 110: 293-301
22. Vazri ND, Bai Y, Ni Z et al. Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction. J Pharmacol Exp Ther 2007; 323: 85-93
23. Nangaku M, Pippin J, Couser WG. C6 mediates chronic progression of tubulointerstitial damage in rats with remnant kidneys. J Am Soc Nephrol 2002; 13: 928-936
24. KDIGO Guidelines: Management of progression and complications of CKD. Kid Int Supplements 2013; 83: 73-90. doi:10.1038/kisup.2012.66
25. Toto RD, Mitchell HC, Smith RD et al. "Strict" blood pressure control and progression of renal disease in hypertensive nephrosclerosis. Kid Int 1995; 48: 851-859
26. Wesson DE, Simoni J, Broglio K et al. Acid retention accompanies reduced GFR in humans and increases plasma levels of endothelin and aldosterone. Am J of Physiol-Renal Physiol 2011; 300: F830-F837
27. MacClean AJ, Hayslett JP. Adaptive change in ammonia excretion in renal insufficiency. Kid Int 1980; 17: 595-606
28. Goodman AD, Lemann J, Jr, Lennon EJ et al. Production, excretion, and net balance of fixed acid in patients with renal failure. J Clin Invest 1980; 17: 595-606
29. Lemann J, Jr, Bushinsky DA, Hamm LL. Bone buffering of acid and base in humans. Am J Physiol 2003; 285: F811-F832
30. Widmer B, Gerhardt RE, Harrington JT et al. The influence of graded degrees of chronic renal failure. Arch Int Med 1979; 139: 1099-1102
31. Wesson DE. Dietary acid increases blood and renal cortical acid content in rats. Am J Physiol 1998; 274: F97-F103
32. Remer T. Influence of nutrition on acid-base balance-metabolic aspects. Eur J Nutr 2001; 40: 214-220
33. Siragy HM et al. Rat renal interstitial bradykinin, prostaglandin E2, and cyclic guanosine 30, 50-monophosphate. Effects of altered sodium intake. Hypertension 1994; 23: 1068-1070
34. Mills KT, Kobori H, Hamm LL et al. Increased urinary excretion of angiotensinogen is associated with risk of chronic kidney disease. Nephrol Dial Transplantation 2012; 27: 3176-3181
35. Kobori H, Harrison-Bernard LM, Navar G. Urinary excretion of angiotensinogen reflects intrarenal angiotensionogen production. Kid Int 2002; 61: 579-585